Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Association analysis between the A118G polymorphism in the OPRM1 gene and treatment response to venlafaxine XR in generalized anxiety disorder.

Cooper AJ, Rickels K, Lohoff FW.

Hum Psychopharmacol. 2013 May;28(3):258-62. doi: 10.1002/hup.2317. Epub 2013 May 8.

PMID:
23658070
2.

Association analysis between the Val66Met polymorphism in the brain-derived neurotrophic factor (BDNF) gene and treatment response to venlafaxine XR in generalized anxiety disorder.

Narasimhan S, Aquino TD, Hodge R, Rickels K, Lohoff FW.

Neurosci Lett. 2011 Oct 10;503(3):200-2. doi: 10.1016/j.neulet.2011.08.035. Epub 2011 Aug 26.

PMID:
21889574
3.

Serotonin receptor 2A (HTR2A) gene polymorphism predicts treatment response to venlafaxine XR in generalized anxiety disorder.

Lohoff FW, Aquino TD, Narasimhan S, Multani PK, Etemad B, Rickels K.

Pharmacogenomics J. 2013 Feb;13(1):21-6. doi: 10.1038/tpj.2011.47. Epub 2011 Oct 18.

PMID:
22006095
4.

Variation in the catechol-O-methyltransferase (COMT) gene and treatment response to venlafaxine XR in generalized anxiety disorder.

Narasimhan S, Aquino TD, Multani PK, Rickels K, Lohoff FW.

Psychiatry Res. 2012 Jun 30;198(1):112-5. doi: 10.1016/j.psychres.2011.12.034. Epub 2012 Mar 13.

PMID:
22417933
5.

Interaction between polymorphisms in serotonin transporter (SLC6A4) and serotonin receptor 2A (HTR2A) genes predict treatment response to venlafaxine XR in generalized anxiety disorder.

Lohoff FW, Narasimhan S, Rickels K.

Pharmacogenomics J. 2013 Oct;13(5):464-9. doi: 10.1038/tpj.2012.33. Epub 2012 Aug 21.

PMID:
22907732
6.
7.

Pattern of symptom improvement following treatment with venlafaxine XR in patients with generalized anxiety disorder.

Meoni P, Salinas E, Brault Y, Hackett D.

J Clin Psychiatry. 2001 Nov;62(11):888-93.

PMID:
11775049
8.
9.

Characterization of the longitudinal course of improvement in generalized anxiety disorder during long-term treatment with venlafaxine XR.

Montgomery SA, Sheehan DV, Meoni P, Haudiquet V, Hackett D.

J Psychiatr Res. 2002 Jul-Aug;36(4):209-17.

PMID:
12191625
10.

Time to relapse after 6 and 12 months' treatment of generalized anxiety disorder with venlafaxine extended release.

Rickels K, Etemad B, Khalid-Khan S, Lohoff FW, Rynn MA, Gallop RJ.

Arch Gen Psychiatry. 2010 Dec;67(12):1274-81. doi: 10.1001/archgenpsychiatry.2010.170.

PMID:
21135327
11.

Does early improvement predict endpoint response in patients with generalized anxiety disorder (GAD) treated with pregabalin or venlafaxine XR?

Baldwin DS, Schweizer E, Xu Y, Lyndon G.

Eur Neuropsychopharmacol. 2012 Feb;22(2):137-42. doi: 10.1016/j.euroneuro.2011.07.005. Epub 2011 Aug 11.

PMID:
21839620
12.

Impact of gastrointestinal symptom severity on response to venlafaxine extended-release in patients with generalized anxiety disorder.

Lydiard RB, Pitrosky B, Hackett D, White C.

J Clin Psychiatry. 2004 Jun;65(6):838-44.

PMID:
15291662
13.
14.

Remission rates with venlafaxine extended release in Greek outpatients with generalized anxiety disorder. A double-blind, randomized, placebo controlled study.

Nimatoudis I, Zissis NP, Kogeorgos J, Theodoropoulou S, Vidalis A, Kaprinis G.

Int Clin Psychopharmacol. 2004 Nov;19(6):331-6.

PMID:
15486518
15.

Generalized anxiety disorder: raising the expectations of treatment.

Allgulander C, Sheehan DV.

Psychopharmacol Bull. 2002 Summer;36 Suppl 2:68-78. Review.

PMID:
17450651
16.

A non-inferiority comparison of duloxetine and venlafaxine in the treatment of adult patients with generalized anxiety disorder.

Allgulander C, Nutt D, Detke M, Erickson J, Spann M, Walker D, Ball S, Russell J.

J Psychopharmacol. 2008 Jun;22(4):417-25. doi: 10.1177/0269881108091588.

PMID:
18635722
17.

Efficacy of once-daily venlafaxine extended release (XR) for symptoms of anxiety in depressed outpatients.

Feighner JP, Entsuah AR, McPherson MK.

J Affect Disord. 1998 Jan;47(1-3):55-62.

PMID:
9476744
18.

Efficacy, safety, and tolerability of venlafaxine extended release and buspirone in outpatients with generalized anxiety disorder.

Davidson JR, DuPont RL, Hedges D, Haskins JT.

J Clin Psychiatry. 1999 Aug;60(8):528-35.

PMID:
10485635
19.

Venlafaxine XR in the treatment of anxiety.

Hackett D.

Acta Psychiatr Scand Suppl. 2000;(406):30-5.

PMID:
11131468
20.

Supplemental Content

Support Center